Global Deep Brain Stimulator Market

Deep Brain Stimulator Comprehensive Study by Type (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), Application (Chronic Pain, Dystonia, Essential Tremor, Depression, Obsessive-compulsive disorder, Epilepsy, Parkinsons Disease, Others), End User (Hospitals, Ambulatory Surgical centers, Neurological clinics) Players and Region - Global Market Outlook to 2028

Deep Brain Stimulator Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 11.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Deep Brain Stimulator Market Scope
Deep Brain Stimulator (DBS) is a neo-surgical device which is used to treat several disabling neurosurgical symptoms and implanting electrodes within certain areas of brain. In addition to this, it is most commonly used in the debilitating motor symptoms of various Parkinson’s disease including rigidity, stiffness, slowed movement, walking problems, tremor. Moreover, it is approved by U.S. Food and Drug Administrator to reduce seizures in difficult-to-treat epilepsy. As reported by American Associations of Neurological Surgeons, over 35,000 DBS implants took place worldwide which suggests that the applications for DBS therapy are expanding rapidly

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Billion)
Key Companies ProfiledSt. Jude Medical (United States), Boston Scientific (United States), Functional Neuromodulation (United States), Medtronic (United States), Aleva Neurotherapeutics (Switzerland), Cyberonics (United States), ElectroCore Medical (United States), EnteroMedics (United States), NeuroMetrix (United States), Abbott Laboratories (United States) and Aleva Neurotherapeutics SA (Switzerland)
CAGR11.2%


"According to AMA, the Global Deep Brain Stimulator market is expected to see growth rate of 11.2% and may see market size of USD2.3 Billion by 2028."

The competitive landscape in the DBS market is expected to continue to intensify in the coming years, as new companies enter the market and existing companies develop new products. This will benefit patients and healthcare providers, as it will lead to more choice, lower prices, and better products. Research Analyst at AMA estimates that United States Players will contribute to the maximum growth of Global Deep Brain Stimulator market throughout the predicted period.

St. Jude Medical (United States), Boston Scientific (United States), Functional Neuromodulation (United States), Medtronic (United States), Aleva Neurotherapeutics (Switzerland), Cyberonics (United States), ElectroCore Medical (United States), EnteroMedics (United States), NeuroMetrix (United States), Abbott Laboratories (United States) and Aleva Neurotherapeutics SA (Switzerland) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Deep Brain Innovations LLC (United States), Beijing Pins Medical Co. Ltd (China) and Sorin Group (United States).

About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.

Segmentation Overview
The study have segmented the market of Global Deep Brain Stimulator market by Type , by Application (Chronic Pain, Dystonia, Essential Tremor, Depression, Obsessive-compulsive disorder, Epilepsy, Parkinsons Disease and Others) and Region with country level break-up.

On the basis of geography, the market of Deep Brain Stimulator has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). region held largest market share in the year 2022.

Market Leaders and their expansionary development strategies
In August 2023, Medtronic and Roche entered into the partnership to develop DBS therapies for Alzheimer's disease. The collaboration brings together Medtronic's expertise in DBS technology with Roche's deep understanding of Alzheimer's disease biology and clinical research capabilities. The two companies have a strong track record of innovation, and they are well-positioned to develop new DBS therapies that could help millions of patients.
In January 2023, Abbott has launched Infinity DBS System which is designed to treat variety of neurological conditions. These system have advanced features, having smaller and powerful battery.
The Drugs under the Drugs and Cosmetics Act 1940 and Rules made thereunder in 1945. A Vision to Streamline Regulation, Incentivize Domestic Manufacturing and Facilitate R&D.

Influencing Trend:
Growing preference for clinical trials and high R&D investments and Increasing robot-assisted implantations and integrated pulse generators

Market Growth Drivers:
Increase geriatric population and rapid rise in incidences of epilepsy globally and Soaring demand for home healthcare and rising healthcare expenditures Increasing incidence of Parkinson’s disease patients

Challenges:
High price of deep brain stimulator devices and Privacy issues related to the data gathered and shared by such devices and government regulations are the major challenges in the growth of the market

Restraints:
Lack of technical knowledge in underdeveloped economies and High cost of devices and risk of infection at the stimulator site

Opportunities:
Increasing treatment of Alzheimers disease and tinnitus, Technological advancements in deep brain stimulators and Expanding applications of deep brain stimulation

Report Objectives / Segmentation Covered

By Type
  • Single Channel Deep Brain Stimulator
  • Dual Channel Deep Brain Stimulator
By Application
  • Chronic Pain
  • Dystonia
  • Essential Tremor
  • Depression
  • Obsessive-compulsive disorder
  • Epilepsy
  • Parkinsons Disease
  • Others
By End User
  • Hospitals
  • Ambulatory Surgical centers
  • Neurological clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase geriatric population and rapid rise in incidences of epilepsy globally
      • 3.2.2. Soaring demand for home healthcare and rising healthcare expenditures Increasing incidence of Parkinson’s disease patients
    • 3.3. Market Challenges
      • 3.3.1. High price of deep brain stimulator devices
      • 3.3.2. Privacy issues related to the data gathered and shared by such devices and government regulations are the major challenges in the growth of the market
    • 3.4. Market Trends
      • 3.4.1. Growing preference for clinical trials and high R&D investments
      • 3.4.2. Increasing robot-assisted implantations and integrated pulse generators
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Deep Brain Stimulator, by Type, Application, End User and Region (value, volume and price ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Deep Brain Stimulator (Value)
      • 5.2.1. Global Deep Brain Stimulator by: Type (Value)
        • 5.2.1.1. Single Channel Deep Brain Stimulator
        • 5.2.1.2. Dual Channel Deep Brain Stimulator
      • 5.2.2. Global Deep Brain Stimulator by: Application (Value)
        • 5.2.2.1. Chronic Pain
        • 5.2.2.2. Dystonia
        • 5.2.2.3. Essential Tremor
        • 5.2.2.4. Depression
        • 5.2.2.5. Obsessive-compulsive disorder
        • 5.2.2.6. Epilepsy
        • 5.2.2.7. Parkinsons Disease
        • 5.2.2.8. Others
      • 5.2.3. Global Deep Brain Stimulator by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory Surgical centers
        • 5.2.3.3. Neurological clinics
      • 5.2.4. Global Deep Brain Stimulator Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Deep Brain Stimulator (Volume)
      • 5.3.1. Global Deep Brain Stimulator by: Type (Volume)
        • 5.3.1.1. Single Channel Deep Brain Stimulator
        • 5.3.1.2. Dual Channel Deep Brain Stimulator
      • 5.3.2. Global Deep Brain Stimulator by: Application (Volume)
        • 5.3.2.1. Chronic Pain
        • 5.3.2.2. Dystonia
        • 5.3.2.3. Essential Tremor
        • 5.3.2.4. Depression
        • 5.3.2.5. Obsessive-compulsive disorder
        • 5.3.2.6. Epilepsy
        • 5.3.2.7. Parkinsons Disease
        • 5.3.2.8. Others
      • 5.3.3. Global Deep Brain Stimulator by: End User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Ambulatory Surgical centers
        • 5.3.3.3. Neurological clinics
      • 5.3.4. Global Deep Brain Stimulator Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Deep Brain Stimulator (Price)
      • 5.4.1. Global Deep Brain Stimulator by: Type (Price)
  • 6. Deep Brain Stimulator: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. St. Jude Medical (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Boston Scientific (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Functional Neuromodulation (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Medtronic (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Aleva Neurotherapeutics (Switzerland)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Cyberonics (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. ElectroCore Medical (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. EnteroMedics (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. NeuroMetrix (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Abbott Laboratories (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Aleva Neurotherapeutics SA (Switzerland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
  • 7. Global Deep Brain Stimulator Sale, by Type, Application, End User and Region (value, volume and price ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Deep Brain Stimulator (Value)
      • 7.2.1. Global Deep Brain Stimulator by: Type (Value)
        • 7.2.1.1. Single Channel Deep Brain Stimulator
        • 7.2.1.2. Dual Channel Deep Brain Stimulator
      • 7.2.2. Global Deep Brain Stimulator by: Application (Value)
        • 7.2.2.1. Chronic Pain
        • 7.2.2.2. Dystonia
        • 7.2.2.3. Essential Tremor
        • 7.2.2.4. Depression
        • 7.2.2.5. Obsessive-compulsive disorder
        • 7.2.2.6. Epilepsy
        • 7.2.2.7. Parkinsons Disease
        • 7.2.2.8. Others
      • 7.2.3. Global Deep Brain Stimulator by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory Surgical centers
        • 7.2.3.3. Neurological clinics
      • 7.2.4. Global Deep Brain Stimulator Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Deep Brain Stimulator (Volume)
      • 7.3.1. Global Deep Brain Stimulator by: Type (Volume)
        • 7.3.1.1. Single Channel Deep Brain Stimulator
        • 7.3.1.2. Dual Channel Deep Brain Stimulator
      • 7.3.2. Global Deep Brain Stimulator by: Application (Volume)
        • 7.3.2.1. Chronic Pain
        • 7.3.2.2. Dystonia
        • 7.3.2.3. Essential Tremor
        • 7.3.2.4. Depression
        • 7.3.2.5. Obsessive-compulsive disorder
        • 7.3.2.6. Epilepsy
        • 7.3.2.7. Parkinsons Disease
        • 7.3.2.8. Others
      • 7.3.3. Global Deep Brain Stimulator by: End User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Ambulatory Surgical centers
        • 7.3.3.3. Neurological clinics
      • 7.3.4. Global Deep Brain Stimulator Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Deep Brain Stimulator (Price)
      • 7.4.1. Global Deep Brain Stimulator by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Deep Brain Stimulator: by Type(USD Billion)
  • Table 2. Deep Brain Stimulator Single Channel Deep Brain Stimulator , by Region USD Billion (2017-2022)
  • Table 3. Deep Brain Stimulator Dual Channel Deep Brain Stimulator , by Region USD Billion (2017-2022)
  • Table 4. Deep Brain Stimulator: by Application(USD Billion)
  • Table 5. Deep Brain Stimulator Chronic Pain , by Region USD Billion (2017-2022)
  • Table 6. Deep Brain Stimulator Dystonia , by Region USD Billion (2017-2022)
  • Table 7. Deep Brain Stimulator Essential Tremor , by Region USD Billion (2017-2022)
  • Table 8. Deep Brain Stimulator Depression , by Region USD Billion (2017-2022)
  • Table 9. Deep Brain Stimulator Obsessive-compulsive disorder , by Region USD Billion (2017-2022)
  • Table 10. Deep Brain Stimulator Epilepsy , by Region USD Billion (2017-2022)
  • Table 11. Deep Brain Stimulator Parkinsons Disease , by Region USD Billion (2017-2022)
  • Table 12. Deep Brain Stimulator Others , by Region USD Billion (2017-2022)
  • Table 13. Deep Brain Stimulator: by End User(USD Billion)
  • Table 14. Deep Brain Stimulator Hospitals , by Region USD Billion (2017-2022)
  • Table 15. Deep Brain Stimulator Ambulatory Surgical centers , by Region USD Billion (2017-2022)
  • Table 16. Deep Brain Stimulator Neurological clinics , by Region USD Billion (2017-2022)
  • Table 17. South America Deep Brain Stimulator, by Country USD Billion (2017-2022)
  • Table 18. South America Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 19. South America Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 20. South America Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 21. Brazil Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 22. Brazil Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 23. Brazil Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 24. Argentina Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 25. Argentina Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 26. Argentina Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 27. Rest of South America Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 28. Rest of South America Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 29. Rest of South America Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 30. Asia Pacific Deep Brain Stimulator, by Country USD Billion (2017-2022)
  • Table 31. Asia Pacific Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 32. Asia Pacific Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 33. Asia Pacific Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 34. China Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 35. China Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 36. China Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 37. Japan Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 38. Japan Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 39. Japan Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 40. India Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 41. India Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 42. India Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 43. South Korea Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 44. South Korea Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 45. South Korea Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 46. Taiwan Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 47. Taiwan Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 48. Taiwan Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 49. Australia Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 50. Australia Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 51. Australia Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 52. Rest of Asia-Pacific Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 53. Rest of Asia-Pacific Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 54. Rest of Asia-Pacific Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 55. Europe Deep Brain Stimulator, by Country USD Billion (2017-2022)
  • Table 56. Europe Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 57. Europe Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 58. Europe Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 59. Germany Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 60. Germany Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 61. Germany Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 62. France Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 63. France Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 64. France Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 65. Italy Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 66. Italy Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 67. Italy Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 68. United Kingdom Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 69. United Kingdom Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 70. United Kingdom Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 71. Netherlands Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 72. Netherlands Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 73. Netherlands Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 74. Rest of Europe Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 75. Rest of Europe Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 76. Rest of Europe Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 77. MEA Deep Brain Stimulator, by Country USD Billion (2017-2022)
  • Table 78. MEA Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 79. MEA Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 80. MEA Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 81. Middle East Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 82. Middle East Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 83. Middle East Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 84. Africa Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 85. Africa Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 86. Africa Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 87. North America Deep Brain Stimulator, by Country USD Billion (2017-2022)
  • Table 88. North America Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 89. North America Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 90. North America Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 91. United States Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 92. United States Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 93. United States Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 94. Canada Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 95. Canada Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 96. Canada Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 97. Mexico Deep Brain Stimulator, by Type USD Billion (2017-2022)
  • Table 98. Mexico Deep Brain Stimulator, by Application USD Billion (2017-2022)
  • Table 99. Mexico Deep Brain Stimulator, by End User USD Billion (2017-2022)
  • Table 100. Deep Brain Stimulator Sales: by Type(K Units)
  • Table 101. Deep Brain Stimulator Sales Single Channel Deep Brain Stimulator , by Region K Units (2017-2022)
  • Table 102. Deep Brain Stimulator Sales Dual Channel Deep Brain Stimulator , by Region K Units (2017-2022)
  • Table 103. Deep Brain Stimulator Sales: by Application(K Units)
  • Table 104. Deep Brain Stimulator Sales Chronic Pain , by Region K Units (2017-2022)
  • Table 105. Deep Brain Stimulator Sales Dystonia , by Region K Units (2017-2022)
  • Table 106. Deep Brain Stimulator Sales Essential Tremor , by Region K Units (2017-2022)
  • Table 107. Deep Brain Stimulator Sales Depression , by Region K Units (2017-2022)
  • Table 108. Deep Brain Stimulator Sales Obsessive-compulsive disorder , by Region K Units (2017-2022)
  • Table 109. Deep Brain Stimulator Sales Epilepsy , by Region K Units (2017-2022)
  • Table 110. Deep Brain Stimulator Sales Parkinsons Disease , by Region K Units (2017-2022)
  • Table 111. Deep Brain Stimulator Sales Others , by Region K Units (2017-2022)
  • Table 112. Deep Brain Stimulator Sales: by End User(K Units)
  • Table 113. Deep Brain Stimulator Sales Hospitals , by Region K Units (2017-2022)
  • Table 114. Deep Brain Stimulator Sales Ambulatory Surgical centers , by Region K Units (2017-2022)
  • Table 115. Deep Brain Stimulator Sales Neurological clinics , by Region K Units (2017-2022)
  • Table 116. South America Deep Brain Stimulator Sales, by Country K Units (2017-2022)
  • Table 117. South America Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 118. South America Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 119. South America Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 120. Brazil Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 121. Brazil Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 122. Brazil Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 123. Argentina Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 124. Argentina Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 125. Argentina Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 126. Rest of South America Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 127. Rest of South America Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 128. Rest of South America Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 129. Asia Pacific Deep Brain Stimulator Sales, by Country K Units (2017-2022)
  • Table 130. Asia Pacific Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 131. Asia Pacific Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 132. Asia Pacific Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 133. China Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 134. China Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 135. China Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 136. Japan Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 137. Japan Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 138. Japan Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 139. India Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 140. India Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 141. India Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 142. South Korea Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 143. South Korea Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 144. South Korea Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 145. Taiwan Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 146. Taiwan Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 147. Taiwan Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 148. Australia Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 149. Australia Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 150. Australia Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 151. Rest of Asia-Pacific Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 152. Rest of Asia-Pacific Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 153. Rest of Asia-Pacific Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 154. Europe Deep Brain Stimulator Sales, by Country K Units (2017-2022)
  • Table 155. Europe Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 156. Europe Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 157. Europe Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 158. Germany Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 159. Germany Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 160. Germany Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 161. France Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 162. France Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 163. France Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 164. Italy Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 165. Italy Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 166. Italy Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 167. United Kingdom Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 168. United Kingdom Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 169. United Kingdom Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 170. Netherlands Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 171. Netherlands Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 172. Netherlands Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 173. Rest of Europe Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 174. Rest of Europe Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 175. Rest of Europe Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 176. MEA Deep Brain Stimulator Sales, by Country K Units (2017-2022)
  • Table 177. MEA Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 178. MEA Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 179. MEA Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 180. Middle East Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 181. Middle East Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 182. Middle East Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 183. Africa Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 184. Africa Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 185. Africa Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 186. North America Deep Brain Stimulator Sales, by Country K Units (2017-2022)
  • Table 187. North America Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 188. North America Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 189. North America Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 190. United States Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 191. United States Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 192. United States Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 193. Canada Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 194. Canada Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 195. Canada Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 196. Mexico Deep Brain Stimulator Sales, by Type K Units (2017-2022)
  • Table 197. Mexico Deep Brain Stimulator Sales, by Application K Units (2017-2022)
  • Table 198. Mexico Deep Brain Stimulator Sales, by End User K Units (2017-2022)
  • Table 199. Deep Brain Stimulator: by Type(USD/Units)
  • Table 200. Company Basic Information, Sales Area and Its Competitors
  • Table 201. Company Basic Information, Sales Area and Its Competitors
  • Table 202. Company Basic Information, Sales Area and Its Competitors
  • Table 203. Company Basic Information, Sales Area and Its Competitors
  • Table 204. Company Basic Information, Sales Area and Its Competitors
  • Table 205. Company Basic Information, Sales Area and Its Competitors
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Deep Brain Stimulator: by Type(USD Billion)
  • Table 212. Deep Brain Stimulator Single Channel Deep Brain Stimulator , by Region USD Billion (2023-2028)
  • Table 213. Deep Brain Stimulator Dual Channel Deep Brain Stimulator , by Region USD Billion (2023-2028)
  • Table 214. Deep Brain Stimulator: by Application(USD Billion)
  • Table 215. Deep Brain Stimulator Chronic Pain , by Region USD Billion (2023-2028)
  • Table 216. Deep Brain Stimulator Dystonia , by Region USD Billion (2023-2028)
  • Table 217. Deep Brain Stimulator Essential Tremor , by Region USD Billion (2023-2028)
  • Table 218. Deep Brain Stimulator Depression , by Region USD Billion (2023-2028)
  • Table 219. Deep Brain Stimulator Obsessive-compulsive disorder , by Region USD Billion (2023-2028)
  • Table 220. Deep Brain Stimulator Epilepsy , by Region USD Billion (2023-2028)
  • Table 221. Deep Brain Stimulator Parkinsons Disease , by Region USD Billion (2023-2028)
  • Table 222. Deep Brain Stimulator Others , by Region USD Billion (2023-2028)
  • Table 223. Deep Brain Stimulator: by End User(USD Billion)
  • Table 224. Deep Brain Stimulator Hospitals , by Region USD Billion (2023-2028)
  • Table 225. Deep Brain Stimulator Ambulatory Surgical centers , by Region USD Billion (2023-2028)
  • Table 226. Deep Brain Stimulator Neurological clinics , by Region USD Billion (2023-2028)
  • Table 227. South America Deep Brain Stimulator, by Country USD Billion (2023-2028)
  • Table 228. South America Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 229. South America Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 230. South America Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 231. Brazil Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 232. Brazil Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 233. Brazil Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 234. Argentina Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 235. Argentina Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 236. Argentina Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 237. Rest of South America Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 238. Rest of South America Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 239. Rest of South America Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 240. Asia Pacific Deep Brain Stimulator, by Country USD Billion (2023-2028)
  • Table 241. Asia Pacific Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 242. Asia Pacific Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 243. Asia Pacific Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 244. China Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 245. China Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 246. China Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 247. Japan Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 248. Japan Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 249. Japan Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 250. India Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 251. India Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 252. India Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 253. South Korea Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 254. South Korea Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 255. South Korea Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 256. Taiwan Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 257. Taiwan Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 258. Taiwan Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 259. Australia Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 260. Australia Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 261. Australia Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 262. Rest of Asia-Pacific Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 263. Rest of Asia-Pacific Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 264. Rest of Asia-Pacific Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 265. Europe Deep Brain Stimulator, by Country USD Billion (2023-2028)
  • Table 266. Europe Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 267. Europe Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 268. Europe Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 269. Germany Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 270. Germany Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 271. Germany Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 272. France Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 273. France Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 274. France Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 275. Italy Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 276. Italy Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 277. Italy Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 278. United Kingdom Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 279. United Kingdom Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 280. United Kingdom Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 281. Netherlands Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 282. Netherlands Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 283. Netherlands Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 284. Rest of Europe Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 285. Rest of Europe Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 286. Rest of Europe Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 287. MEA Deep Brain Stimulator, by Country USD Billion (2023-2028)
  • Table 288. MEA Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 289. MEA Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 290. MEA Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 291. Middle East Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 292. Middle East Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 293. Middle East Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 294. Africa Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 295. Africa Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 296. Africa Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 297. North America Deep Brain Stimulator, by Country USD Billion (2023-2028)
  • Table 298. North America Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 299. North America Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 300. North America Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 301. United States Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 302. United States Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 303. United States Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 304. Canada Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 305. Canada Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 306. Canada Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 307. Mexico Deep Brain Stimulator, by Type USD Billion (2023-2028)
  • Table 308. Mexico Deep Brain Stimulator, by Application USD Billion (2023-2028)
  • Table 309. Mexico Deep Brain Stimulator, by End User USD Billion (2023-2028)
  • Table 310. Deep Brain Stimulator Sales: by Type(K Units)
  • Table 311. Deep Brain Stimulator Sales Single Channel Deep Brain Stimulator , by Region K Units (2023-2028)
  • Table 312. Deep Brain Stimulator Sales Dual Channel Deep Brain Stimulator , by Region K Units (2023-2028)
  • Table 313. Deep Brain Stimulator Sales: by Application(K Units)
  • Table 314. Deep Brain Stimulator Sales Chronic Pain , by Region K Units (2023-2028)
  • Table 315. Deep Brain Stimulator Sales Dystonia , by Region K Units (2023-2028)
  • Table 316. Deep Brain Stimulator Sales Essential Tremor , by Region K Units (2023-2028)
  • Table 317. Deep Brain Stimulator Sales Depression , by Region K Units (2023-2028)
  • Table 318. Deep Brain Stimulator Sales Obsessive-compulsive disorder , by Region K Units (2023-2028)
  • Table 319. Deep Brain Stimulator Sales Epilepsy , by Region K Units (2023-2028)
  • Table 320. Deep Brain Stimulator Sales Parkinsons Disease , by Region K Units (2023-2028)
  • Table 321. Deep Brain Stimulator Sales Others , by Region K Units (2023-2028)
  • Table 322. Deep Brain Stimulator Sales: by End User(K Units)
  • Table 323. Deep Brain Stimulator Sales Hospitals , by Region K Units (2023-2028)
  • Table 324. Deep Brain Stimulator Sales Ambulatory Surgical centers , by Region K Units (2023-2028)
  • Table 325. Deep Brain Stimulator Sales Neurological clinics , by Region K Units (2023-2028)
  • Table 326. South America Deep Brain Stimulator Sales, by Country K Units (2023-2028)
  • Table 327. South America Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 328. South America Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 329. South America Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 330. Brazil Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 331. Brazil Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 332. Brazil Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 333. Argentina Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 334. Argentina Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 335. Argentina Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 336. Rest of South America Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 337. Rest of South America Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 338. Rest of South America Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 339. Asia Pacific Deep Brain Stimulator Sales, by Country K Units (2023-2028)
  • Table 340. Asia Pacific Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 341. Asia Pacific Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 342. Asia Pacific Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 343. China Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 344. China Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 345. China Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 346. Japan Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 347. Japan Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 348. Japan Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 349. India Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 350. India Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 351. India Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 352. South Korea Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 353. South Korea Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 354. South Korea Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 355. Taiwan Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 356. Taiwan Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 357. Taiwan Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 358. Australia Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 359. Australia Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 360. Australia Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 361. Rest of Asia-Pacific Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 362. Rest of Asia-Pacific Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 363. Rest of Asia-Pacific Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 364. Europe Deep Brain Stimulator Sales, by Country K Units (2023-2028)
  • Table 365. Europe Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 366. Europe Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 367. Europe Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 368. Germany Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 369. Germany Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 370. Germany Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 371. France Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 372. France Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 373. France Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 374. Italy Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 375. Italy Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 376. Italy Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 377. United Kingdom Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 378. United Kingdom Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 379. United Kingdom Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 380. Netherlands Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 381. Netherlands Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 382. Netherlands Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 383. Rest of Europe Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 384. Rest of Europe Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 385. Rest of Europe Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 386. MEA Deep Brain Stimulator Sales, by Country K Units (2023-2028)
  • Table 387. MEA Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 388. MEA Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 389. MEA Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 390. Middle East Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 391. Middle East Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 392. Middle East Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 393. Africa Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 394. Africa Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 395. Africa Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 396. North America Deep Brain Stimulator Sales, by Country K Units (2023-2028)
  • Table 397. North America Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 398. North America Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 399. North America Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 400. United States Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 401. United States Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 402. United States Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 403. Canada Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 404. Canada Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 405. Canada Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 406. Mexico Deep Brain Stimulator Sales, by Type K Units (2023-2028)
  • Table 407. Mexico Deep Brain Stimulator Sales, by Application K Units (2023-2028)
  • Table 408. Mexico Deep Brain Stimulator Sales, by End User K Units (2023-2028)
  • Table 409. Deep Brain Stimulator: by Type(USD/Units)
  • Table 410. Research Programs/Design for This Report
  • Table 411. Key Data Information from Secondary Sources
  • Table 412. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Deep Brain Stimulator: by Type USD Billion (2017-2022)
  • Figure 5. Global Deep Brain Stimulator: by Application USD Billion (2017-2022)
  • Figure 6. Global Deep Brain Stimulator: by End User USD Billion (2017-2022)
  • Figure 7. South America Deep Brain Stimulator Share (%), by Country
  • Figure 8. Asia Pacific Deep Brain Stimulator Share (%), by Country
  • Figure 9. Europe Deep Brain Stimulator Share (%), by Country
  • Figure 10. MEA Deep Brain Stimulator Share (%), by Country
  • Figure 11. North America Deep Brain Stimulator Share (%), by Country
  • Figure 12. Global Deep Brain Stimulator: by Type K Units (2017-2022)
  • Figure 13. Global Deep Brain Stimulator: by Application K Units (2017-2022)
  • Figure 14. Global Deep Brain Stimulator: by End User K Units (2017-2022)
  • Figure 15. South America Deep Brain Stimulator Share (%), by Country
  • Figure 16. Asia Pacific Deep Brain Stimulator Share (%), by Country
  • Figure 17. Europe Deep Brain Stimulator Share (%), by Country
  • Figure 18. MEA Deep Brain Stimulator Share (%), by Country
  • Figure 19. North America Deep Brain Stimulator Share (%), by Country
  • Figure 20. Global Deep Brain Stimulator: by Type USD/Units (2017-2022)
  • Figure 21. Global Deep Brain Stimulator share by Players 2022 (%)
  • Figure 22. Global Deep Brain Stimulator share by Players (Top 3) 2022(%)
  • Figure 23. Global Deep Brain Stimulator share by Players (Top 5) 2022(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. St. Jude Medical (United States) Revenue, Net Income and Gross profit
  • Figure 26. St. Jude Medical (United States) Revenue: by Geography 2022
  • Figure 27. Boston Scientific (United States) Revenue, Net Income and Gross profit
  • Figure 28. Boston Scientific (United States) Revenue: by Geography 2022
  • Figure 29. Functional Neuromodulation (United States) Revenue, Net Income and Gross profit
  • Figure 30. Functional Neuromodulation (United States) Revenue: by Geography 2022
  • Figure 31. Medtronic (United States) Revenue, Net Income and Gross profit
  • Figure 32. Medtronic (United States) Revenue: by Geography 2022
  • Figure 33. Aleva Neurotherapeutics (Switzerland) Revenue, Net Income and Gross profit
  • Figure 34. Aleva Neurotherapeutics (Switzerland) Revenue: by Geography 2022
  • Figure 35. Cyberonics (United States) Revenue, Net Income and Gross profit
  • Figure 36. Cyberonics (United States) Revenue: by Geography 2022
  • Figure 37. ElectroCore Medical (United States) Revenue, Net Income and Gross profit
  • Figure 38. ElectroCore Medical (United States) Revenue: by Geography 2022
  • Figure 39. EnteroMedics (United States) Revenue, Net Income and Gross profit
  • Figure 40. EnteroMedics (United States) Revenue: by Geography 2022
  • Figure 41. NeuroMetrix (United States) Revenue, Net Income and Gross profit
  • Figure 42. NeuroMetrix (United States) Revenue: by Geography 2022
  • Figure 43. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 44. Abbott Laboratories (United States) Revenue: by Geography 2022
  • Figure 45. Aleva Neurotherapeutics SA (Switzerland) Revenue, Net Income and Gross profit
  • Figure 46. Aleva Neurotherapeutics SA (Switzerland) Revenue: by Geography 2022
  • Figure 47. Global Deep Brain Stimulator: by Type USD Billion (2023-2028)
  • Figure 48. Global Deep Brain Stimulator: by Application USD Billion (2023-2028)
  • Figure 49. Global Deep Brain Stimulator: by End User USD Billion (2023-2028)
  • Figure 50. South America Deep Brain Stimulator Share (%), by Country
  • Figure 51. Asia Pacific Deep Brain Stimulator Share (%), by Country
  • Figure 52. Europe Deep Brain Stimulator Share (%), by Country
  • Figure 53. MEA Deep Brain Stimulator Share (%), by Country
  • Figure 54. North America Deep Brain Stimulator Share (%), by Country
  • Figure 55. Global Deep Brain Stimulator: by Type K Units (2023-2028)
  • Figure 56. Global Deep Brain Stimulator: by Application K Units (2023-2028)
  • Figure 57. Global Deep Brain Stimulator: by End User K Units (2023-2028)
  • Figure 58. South America Deep Brain Stimulator Share (%), by Country
  • Figure 59. Asia Pacific Deep Brain Stimulator Share (%), by Country
  • Figure 60. Europe Deep Brain Stimulator Share (%), by Country
  • Figure 61. MEA Deep Brain Stimulator Share (%), by Country
  • Figure 62. North America Deep Brain Stimulator Share (%), by Country
  • Figure 63. Global Deep Brain Stimulator: by Type USD/Units (2023-2028)
List of companies from research coverage that are profiled in the study
  • St. Jude Medical (United States)
  • Boston Scientific (United States)
  • Functional Neuromodulation (United States)
  • Medtronic (United States)
  • Aleva Neurotherapeutics (Switzerland)
  • Cyberonics (United States)
  • ElectroCore Medical (United States)
  • EnteroMedics (United States)
  • NeuroMetrix (United States)
  • Abbott Laboratories (United States)
  • Aleva Neurotherapeutics SA (Switzerland)
Additional players considered in the study are as follows:
Deep Brain Innovations LLC (United States) , Beijing Pins Medical Co. Ltd (China) , Sorin Group (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 205 Pages 80 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Deep Brain Stimulator Market Quantitative research analysis
Global Deep Brain Stimulator Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The key segments that are playing vital role in Deep Brain Stimulator Market are by type [Single Channel Deep Brain Stimulator and Dual Channel Deep Brain Stimulator], by end use application [Chronic Pain, Dystonia, Essential Tremor, Depression, Obsessive-compulsive disorder, Epilepsy, Parkinsons Disease and Others].
The Deep Brain Stimulator Market is gaining popularity and expected to see strong valuation by 2028.
  • Increase geriatric population and rapid rise in incidences of epilepsy globally
  • Soaring demand for home healthcare and rising healthcare expenditures Increasing incidence of Parkinson’s disease patients

Know More About Global Deep Brain Stimulator Market Report?

Have a Query? Click Here

Other Related Reports

Veterinary Masks Comprehensive Study by Type (Anesthesia Mask, Oxygen Mask, Surgical Mask, Other), Application (Pet Hospital, Veterinary Station), Distribution Channel (Online, Offline) Players and R...
$ 3500
Manual Phoropters Comprehensive Study by Type (Stationary, Portable), Application (Optical Shops, Hospitals, Other) Players and Region - Global Market Outlook to 2026
$ 3500
Non-Invasive Blood Glucose Monitoring Devices Comprehensive Study by Type (Spectroscopy Monitoring, Optical Coherence Tomography Monitoring, Electromagnetic Monitoring, Polarimetry Monitoring, Others...
$ 3750
Spinal Non Fusion Technologies Comprehensive Study by Type (Dynamic stabilization devices, Disc nucleus replacement products, Annulus repair devices, Nuclear disc prostheses, Disc arthroplasty device...
$ 3800
Digital Mammography Equipment Comprehensive Study by Type (Analog Systems, Full Field Digital mammography (FFDM), Breast Tomosynthesis Systems), Technology (Screen Film, 2D Mammography, 3D Mammograph...
$ 3450
Orthopedic Splints Comprehensive Study by Type (Plaster Splints, Fiberglass Splints, Splinting Tools and Accessories, Other Splints), Application (Lower Extremity Splints, Upper Extremity Splints, Sp...
$ 3650